GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gelstat GSAC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 5 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$267,962

FY2014FY2025

Net income

−$326,575

FY2014FY2025

Free cash flow

−$62,807

FY2014FY2025

Shareholders' equity

−$1.3m

FY2014FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2014
Revenue$267,962$349,730$149,527$2,333$7,022$3,950$201,000—$1.3m
Operating income−$241,853−$281,000−$165,827−$602,000−$313,000−$177,547$175,000−$8,839−$1.3m
Net income−$326,575−$373,000−$210,111−$761,000−$475,000−$177,838$175,000−$8,839−$1.3m
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.000.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2014
Total assets$269,576$170,888$185,879$18,830$182,090$140,220$100,000$75$7.0m
Cash and short-term investments$5,387$8,825$25,313$1,730$67,138$767$1,000$75$96,680
Total liabilities$1.5m$1.2m$964,371$724,085$511,058$343,945$320,000$20,172$1.4m
Debt$853,407$664,555$583,967$363,165$256,099$197,005$2,000—$17,198
Shareholders' equity−$1.3m−$1.0m−$778,492−$705,255−$328,968−$203,725−$220,000−$20,097$5.7m
Shares outstanding3,065m3,330m1,817m674m532m500m3,065m3,065m365m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2014
Cash from operations−$62,803−$57,167−$106,289−$172,376−$204,858−$85,219−$172,000−$275,040−$239,158
Capital spending−$4−$3−$1−$4————−$4,579
Free cash flow−$62,807−$57,170−$106,290−$172,380−$204,858−$85,219−$172,000−$275,040−$243,737

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
Revenue$80,081$64,519$117,247$117,247$77,923$57,618$62,437$34,705
Operating income−$69,677−$81,147−$140,000−$140,000−$17,424−$121,955$31,143−$75,073
Net income−$99,982−$105,322−$36,378−$36,378−$45,409−$150,096$36,584−$82,445
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.000.00-0.00
Total assets$319,488—$170,888$170,888$172,592—$185,879$193,108
Cash and short-term investments$71,412$8,825$8,825$8,825$6,672$25,313$25,313$37,464
Debt$67,655—$440,065$440,065$223,893—$66,473$43,536
Shareholders' equity−$1.2m−$1.0m−$1.0m−$1.0m−$1.0m−$778,492−$778,492−$802,476

Growth per year

Compound annual rate

3 years5 years10 years
Revenue386.1%132.4%28.7%
Operating income-26.2%6.4%-5.0%
Net income-24.6%12.9%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-84.6%-167.7%-228.2%—
Net margin-113.3%-217.1%-297.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2018
Price to earnings-3.3-1.6-1.6-0.3-1.2-0.0-0.0
Price to sales4.01.72.297.583.40.3—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return94%-25%-35%-42%21156%999%756%3528%112422%560%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 3-for-2 split · 1 Sept 2004
  • 2-for-1 split · 21 Oct 2003
  • 3-to-1 reverse split · 12 Dec 1995

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.